Bellerophon, which was spun out of biopharmaceutical company Ikaria last year, has filed for an initial public offering on Nasdaq.

The Hubert Burda-backed online handmade goods marketplace has raised more than $90m in venture capital over the last decade.

The Genomic Health-backed genetic testing company intends to raise $86m from an initial public offering on the New York Stock Exchange.

Juno Therapeutics completes initial public offering, with stocks soaring.

Spark Therapeutics, a spin-out of Children's Hospital of Philadelphia, is developing gene therapy treatments for a rare blinding disorder and haemophilia.

Mobile game developer Linekong previously $115m in three funding rounds from investors including IDG Capital Partners.

Spark Therapeutics, a drug developer spinout of Children's Hospital of Philadelphia, is set to go public on Nasdaq.

The molecular profiling company, backed by Novo, GlaxoSmithKline and Merck, is seeking to float on Nasdaq.